search menu icon-carat-right cmu-wordmark

CERT Coordination Center

Fortinet FortiADC D-series contains a cross-site scripting vulnerability

Vulnerability Note VU#667340

Original Release Date: 2014-04-11 | Last Revised: 2014-04-15

Overview

Fortinet FortiADC D-series 3.2.0, and possibly earlier versions, contains a cross-site scripting vulnerability. (CWE-79)

Description

CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

Fortinet FortiADC D-series 3.2.0, and possibly earlier versions, contains a cross-site scripting vulnerability. The "locale" parameter in the "/FortiADC/gui_partA/?locale=en" page is vulnerable to a reflected cross-site scripting attack.

Impact

A remote unauthenticated attacker may be able to execute arbitrary script in the context of the end-user's browser session.

Solution

Apply an Update

FortiADC D-series 3.2.1 has been released to address this vulnerability.

Restrict access

As a general good security practice, only allow connections from trusted hosts and networks. Note that restricting access does not prevent XSS attacks since the attack comes as an HTTP request from a legitimate user's host. Restricting access would prevent an attacker from accessing the FortiADC interface using stolen credentials from a blocked network location.

Vendor Information

667340
 

Fortinet, Inc. Affected

Notified:  February 07, 2014 Updated: April 11, 2014

Status

Affected

Vendor Statement

We have not received a statement from the vendor.

Vendor Information

We are not aware of further vendor information regarding this vulnerability.


CVSS Metrics

Group Score Vector
Base 4.3 AV:N/AC:M/Au:N/C:P/I:N/A:N
Temporal 3.7 E:POC/RL:W/RC:C
Environmental 2.8 CDP:ND/TD:M/CR:ND/IR:ND/AR:ND

References

Acknowledgements

Thanks to William Costa for reporting this vulnerability.

This document was written by Jared Allar.

Other Information

CVE IDs: CVE-2014-0331
Date Public: 2014-04-11
Date First Published: 2014-04-11
Date Last Updated: 2014-04-15 19:58 UTC
Document Revision: 24

Sponsored by CISA.